Literature DB >> 17470292

Toll-like receptor 2 signaling is a mediator of apoptosis in herpes simplex virus-infected microglia.

Rajagopal N Aravalli1, Shuxian Hu, James R Lokensgard.   

Abstract

BACKGROUND: Information regarding the response of brain cells to infection with herpes simplex virus (HSV)-1 is needed for a complete understanding of viral neuropathogenesis. We have recently demonstrated that microglial cells respond to HSV infection by producing a number of proinflammatory cytokines and chemokines through a mechanism involving Toll-like receptor 2 (TLR2). Following this cytokine burst, microglial cells rapidly undergo cell death by apoptosis. We hypothesized that TLR2 signaling might mediate the cell death process as well.
METHODS: To test this hypothesis, we investigated HSV-induced cell death of microglia obtained from both wild-type and TLR2-/- mice. Cell death was studied by oligonucleosomal ELISA and TUNEL staining, and the mechanisms of apoptosis were further analyzed using murine apoptosis-specific microarrays. The data obtained from microarray analysis were then validated using quantitative real-time PCR assays.
RESULTS: HSV infection induced apoptotic cell death in microglial cells from wild-type as well as TLR2 cells. However, the cell death at 24 h p.i. was markedly lower in knockout cells. Furthermore, microarray analyses clearly showed that the expression of pro-apoptotic genes was down-regulated at the time when wild-type cells were actively undergoing apoptosis, indicating a differential response to HSV in cells with or without TLR2.
CONCLUSION: We demonstrate here that HSV induces an apoptotic response in microglial cells which is mediated through TLR2 signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17470292      PMCID: PMC1866225          DOI: 10.1186/1742-2094-4-11

Source DB:  PubMed          Journal:  J Neuroinflammation        ISSN: 1742-2094            Impact factor:   8.322


Background

In the central nervous system (CNS), microglial cells generate the first line of defense against invading pathogens [1]. They are key immune cells that survey the brain parenchyma. During early onset of infection, microglia become activated and produce proinflammatory cytokines and chemokines. Production of these proinflammatory mediators may result in the infiltration of lymphocytes across the blood-brain barrier to sites of viral infection [2]. Microglia are functionally very similar to macrophages in that they clear up dead neurons and other cell debris by phagocytosis [1,2]. Therefore, efficient immune functions by microglial cells may be critical in controlling a number of CNS infections. Herpes simplex virus 1 (HSV-1) is a neurotropic virus that infects a wide range of mammalian cells. Following primary infection of epithelial cells, HSV gains access to the nervous system and establishes latency in ganglionic neurons. Viral reactivation from this latent state may result in herpes encephalitis. A number of studies have demonstrated that Toll-like receptor (TLR) signaling in microglia is critical in generating innate immune responses against viral pathogens in the CNS [3-7]. In cell lines, HSV infection has been shown to activate signaling from TLR2 and TLR9 [4,8,9]. While TLR2 is localized on the cell surface, TLR9 is expressed intracellularly on lysosomal membranes. In a recent report, TLR2-deficient neonatal mice were found to be less susceptible to encephalitis caused by HSV, suggesting that TLR2 plays an important role in disease pathogenesis [4]. We have previously shown that microglial cells respond to HSV-1 by producing a large number of proinflammatory immune mediators in a TLR2-dependent manner [3]. Interestingly, however, these cells undergo apoptotic cell death following immune mediator production [10]. Although activation of TLR signaling has been shown to induce apoptosis in cell lines [11,12], little is known about TLR involvement in cell death of primary brain cells. In this study, we hypothesized that TLR2 signaling induces HSV-mediated microglial cell apoptosis.

Methods

Preparation of microglial cell cultures

Wild type and TLR2-/- C57BL/6 mice were purchased from the Jackson Laboratories (Bar Harbor, ME). Purified microglial cell cultures (>99% pure), as determined by MAC-1 antibody staining (Roche Applied Science, Indianapolis, IN), were prepared from these mice using a previously described method with minor modifications [13]. Growth medium for microglial cell cultures was Dulbecco's modified Eagle's medium (DMEM) with 10% heat-inactivated fetal calf serum (HyClone Laboratories, Logan, UT) and antibiotics. For microarray analysis and real-time PCR assay, 1 × 106 cells/sample were used. For oligonucleosomal ELISA and TUNEL staining, 2 × 105 cells were used.

Virus

A highly neurotropic HSV-1 17 syn+ strain, propagated and purified from rabbit skin fibroblasts, was used for infection studies at a multiplicity of infection (MOI) of 2. After adding virus, culture plates were incubated at 37°C for the indicated time points.

Oligonucleosomal ELISA

A sandwich ELISA-based system (Roche Applied Science) was used to detect nucleosomes generated due to DNA fragmentation during apoptosis. The assay was performed at the indicated time points as per the manufacturer's instructions. Data are representative of three independent experiments, and bars represent the mean + SD of triplicate samples.

TUNEL staining

Wild type and TLR2-/- microglial cells were infected with HSV (MOI = 2) and DNA fragmentation was determined by terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-X nick end labeling (TUNEL) using the ApopTag ® peroxidasein situ apoptosis detection kit (Millipore, Temecula, CA). Microglial cells were cultured on Lab-Tek chamber slides at a density of 2 × 105 cells per well. At the end of the incubation period, cells were fixed in 4% paraformaldehyde for 20 min followed by a staining procedure according to the manufacturer's protocol.

Microarrays

Mouse-specific OligoGEArray® apoptosis microarrays (OMM-12) (SuperArray, Frederick, MD) were used for our studies, and hybridization procedures were performed per manufacturer's instructions. Wild type and TLR2-/- microglial cells were treated with HSV, and total RNA was extracted after 8 h and 24 h post-infection (p.i.) using the RNeasy mini kit (Qiagen, Valencia, CA). Following the chemiluminescent detection steps, positive spots on arrays were scanned using a Kodak Image Station 2000R (Molecular Imaging Systems, Rochester, NY) and were quantified using GEA analysis suite software (SuperArray). Data were analyzed as relative induction after each gene was normalized to the house-keeping gene GAPDH.

Quantitative real-time PCR

cDNA was synthesized using 1 μg of total RNA from uninfected and infected wild-type and TLR2-/- microglia, at 8 h and 16 h p.i,. using Superscript II reverse transcriptase (Invitrogen, Carlsbad, CA) and oligo dT6–12 primers (Sigma-Genosys, The Woodlands, TX). PCR was performed with the FullVelocity SYBR Green QPCR master mix (Stratagene, La Jolla, CA). The PCR conditions for the Mx3000P QPCR System (Stratagene) were: 40 denaturation cycles of 95°C for 10 s, annealing at 60°C for 10 s and elongation at 72°C for 10 s. The relative product levels were quantified using the 2(-Delta Delta C(T)) method [14] and were normalized to β-actin, and are representative of three independent experiments. Forward and reverse primer sequences used in the study: caspase-3: 5'-gggcctgaaataccaagtca-3' and 5'-aaatgaccccttcatcacca-3'; Dsip1: 5'-ggtggccctagacaacaaga-3' and 5'-tcaagcagctcacgaatctg-3'; CIDE-B: 5' ctggaactcagctcctccac-3' and 5'- cctccaggaccagtgttagc-3'; caspase-2: 5'- cagctccaagaggtttttcg-3' and 5'- acatccaggggattgtgtgt-3'; Tnfrsf12a: 5'-gattcggcttggtgttgatg-3' and 5'-cagtccatgcacttgtcgag-3'; RipK2: 5' cagctgggatggtatcgttt-3' and 5'- tggttaaggcaggcttcagt-3'.

Results and discussion

TLR2 signaling mediates HSV-induced apoptosis in murine microglia

To test the hypothesis that TLR2 signaling is involved in the induction of apoptosis in HSV-infected microglia, 2 × 105 cells/sample were infected with the neurotropic HSV-1 strain 17 syn+. We have previously demonstrated that HSV infects both wild-type and TLR2-/- microglia with similar efficiencies [3], and that apoptosis in virus-infected wild-type microglia peaks at 24 h p.i. [10]. Following these observations, we harvested cells at 8 h and 24 h p.i., to reflect early and peak apoptotic time points, and performed oligonucleosomal ELISA assay to detect nucleosomes generated as a result of DNA fragmentation. As shown in Fig. 1A, cell death was not observed at significant levels in either wild-type or TLR2-/- microglia at 8 h p.i. However, apoptosis was induced in wild-type cells at 24 h p.i. The extent of HSV-induced cell death observed in TLR2-/- microglia at 24 h p.i. was 40% of that seen in wild-type microglia. To confirm apoptotic death in these cells, TUNEL assay was performed using wild type and TLR2-/- microglial cells following a 24 h infection with HSV. As shown in Fig. 1B, HSV-induced apoptosis was found to be markedly lower in TLR2-/- microglia than in wild type cells, further demonstrating that TLR2 signaling plays a role in regulating microglial cell apoptosis in response to HSV.
Figure 1

HSV infection induces apoptosis in murine microglial cells. Wild-type and TLR2-/- C57BL/6 microglial cells were infected with HSV at a MOI of 2. (A) The cells were examined for apoptotic DNA fragmentation using an oligonucleosomal ELISA at 8 and 24 h p.i. Data are presented as optical density (OD) per 104 cells and are representative of three independent experiments using cells isolated from different brain specimens. (B) TUNEL staining of wild-type and TLR2-/- microglia at 24 h p.i. After fixing and staining the wells, TUNEL positive cells from at least five fields were counted for each well. Data presented were representative of three independent experiments.

HSV infection induces apoptosis in murine microglial cells. Wild-type and TLR2-/- C57BL/6 microglial cells were infected with HSV at a MOI of 2. (A) The cells were examined for apoptotic DNA fragmentation using an oligonucleosomal ELISA at 8 and 24 h p.i. Data are presented as optical density (OD) per 104 cells and are representative of three independent experiments using cells isolated from different brain specimens. (B) TUNEL staining of wild-type and TLR2-/- microglia at 24 h p.i. After fixing and staining the wells, TUNEL positive cells from at least five fields were counted for each well. Data presented were representative of three independent experiments.

Differential expression of apoptotic genes in HSV-infected wild-type and TLR2-/- microglial cells

To further investigate differences in cell death between HSV-infected wild-type and TLR2-/- cells, and to study the expression profiles of apoptotic genes, we performed microarray analyses using mouse-specific apoptosis microarrays. These arrays contained most murine apoptotic genes. Since gene expression occurs several hours ahead of DNA fragmentation, 8 h and 16 h p.i. time points were selected for this study. Furthermore, an induction or down-regulation of at least two-fold or higher of a given gene was considered significant in either inducing or blocking apoptosis. As shown in Tables 1 and 2, the expression profiles of the apoptotic genes were markedly different between wild-type and in TLR2-/- microglial cells. At 8 h p.i., the expression of most apoptotic genes remained unchanged in wild-type cells, while TLR2-/- cells showed induction of few genes. At 16 h p.i., however, pro-apoptotic genes such as caspase-3 and caspase-8 were highly expressed in wild-type cells demonstrating that they were actively undergoing apoptosis. Interestingly, these genes were not expressed in TLR2-/- cells at this time point. Moreover, many pro-apoptotic genes were down-regulated in TLR2-/- cells at 16 h p.i. when compared with their expression at 8 h p.i.
Table 1

Expression of apoptotic genes in HSV-infected microglial cells from C57BL/6 mice

SymbolGeneFold change
8 h16 h
Casp3Caspase-32.393.79
Card15Caspase recruitment domain family member 15-2.04
Casp11Caspase-110.852.38
Casp8Caspase-8-0.672.41
Dsip1TSC22 domain family 3-0.263.04
Tnfrsf12aTNF receptor superfamily member 12a2.320.84
Atf5Activating transcription factor-2.24-1.22
Bcl10B-cell leukemia/lymphoma 10-2.50-0.94
BidBH3 interacting domain death agonist-2.15-1.03
Dad1Defender against cell death-2.17-1.40
Mapk8ip1MAP kinase interacting protein 1-4.02-4.06
Rnf7Ring finger protein 7-4.44-1.81
PolbPolymerase B-5.08-1.82
Prdx2Peroxiredoxin 2-3.49-2.14
LtbrLymphotoxin B receptor-3.00-1.98
Tnfrsf21TNF receptor superfamily member 21-4.70-5.88
Traf3TNF receptor-associated factor 3-3.52-2.07
Table 2

Expression of apoptotic genes in HSV-infected TLR2KO microglial cells.

SymbolGeneFold change
8 h16 h
Tnfsf10TNF ligand superfamily member 108.665.59
Casp12Caspase-124.151.00
RipK2Receptor (Tnfrsf)-interacting kinase23.382.87
Casp8ap2Caspase-8-associated protein 23.360.66
FaslFas ligand3.151.37
Casp3Caspase-32.911.46
TnfTumor necrosis factor2.711.35
CflarCasp-8 and FADD-like apoptosis regulator2.500.90
Tnfrsf5TNF superfamily member 52.350.93
Bag4BCL2-associated athanogene 42.160.58
BadBcl-associated death promoter-3.00-5.07
AktThymoma viral proto-oncogene1-3.76-2.56
Als2cr2Als chromosome region candidate 2-3.97-2.38
BaxBcl2-associated X protein-2.35-1.49
Bcl10B-cell leukemia/lymphoma 10-2.71-3.44
Birc5Baculoviral IAP repeat-containing 5-2.19-8.87
Bcl2l14Bcl2-like 14 (apoptosis facilitator)-2.08-4.08
BidBH3 interacting domain death agonist-0.97-2.21
Bnip3lBCL2/adenovirus E1B-interacting protein-4.94-5.14
Birc6Baculoviral IAP repeat-containing 6-1.35-3.19
Bnip2BCL2/adenovirus E1B-interacting protein-1.04-2.56
Api5Apoptosis inhibitor 5-4.01-2.56
Dsip1TSC22 domain family 3-2.55-1.50
CidebCell-death inducing DNA fragmentation factor 2-1.78-3.42
CraddCASP2 and RIPK1 adaptor domain containing protein-1.54-6.32
FaddFas-associated death domain-1.21-2.92
FaimFas apoptotic inhibitory molecule-1.81-3.18
HellsHelicase lymphoid specific-0.84-2.24
Il10Interleukin 10-1.27-2.21
Mapk8ip1MAP kinase interacting protein 1-0.87-5.75
Zc3hc1C3HC type zinc finger protein-0.93-2.25
Nfkb1NF-κB-1.92-1.55
Rnf7Ring finger protein 7-2.81-2.31
Pak7P21 (CDKN1A)-activated kinase 7-0.85-2.03
Traf3TNF receptor-associated factor 3-6.31-2.71
Tnfrsf21TNF receptor superfamily member 21-1.87-1.75
Trp53P53-2.80-1.17
Expression of apoptotic genes in HSV-infected microglial cells from C57BL/6 mice Expression of apoptotic genes in HSV-infected TLR2KO microglial cells.

Validation of apoptotic gene expression in HSV-infected microglia

To further confirm these findings, we performed quantitative real-time PCR for six different apoptotic genes selected from the microarray data. These genes were found to be either up-regulated or down-regulated in HSV-infected wild-type microglia and were down-regulated in TLR2-/- cells (Tables 1 &2). As shown in Fig. 2, the expression levels of caspase-2, caspase-3, Cide-B and Dsip1 increased in wild-type cells between 8 h to 16 h p.i. whereas they were down-regulated from basal expression in uninfected controls. On the other hand, Tnfrsf12a and RipK2 were down-regulated both in wild-type and TLR2-/- cells. These data further demonstrate that TLR2-/- cells have significantly lower levels of pro-apoptotic gene expression than wild-type cells, and that TLR2 signaling mediates apoptotic cell death in HSV-infected microglial cells. We have previously shown that the levels of TNF-α expression in TLR2-/- microglia were approximately 50% of those seen in wild-type cells [3]. In this study, apoptotic death in TLR2-/- cells was found to be 40% of that in wild-type microglia and, therefore, it is possible that TNF-α, as well as other immune mediators, might eventually trigger apoptosis in cells lacking TLR2.
Figure 2

Differential expression of apoptotic genes in microglial cells obtained from wild-type and TLR2-/- mice. Real-time PCR was performed using RNA from uninfected and HSV-infected microglia with primers specific for the apoptotic genes indicated. β-actin was used to normalize the values of apoptotic genes tested. Data presented are representative of three independent experiments.

Differential expression of apoptotic genes in microglial cells obtained from wild-type and TLR2-/- mice. Real-time PCR was performed using RNA from uninfected and HSV-infected microglia with primers specific for the apoptotic genes indicated. β-actin was used to normalize the values of apoptotic genes tested. Data presented are representative of three independent experiments.

Conclusion

In this study, we showed that TLR2 signaling induces apoptosis in HSV-infected microglia. Although the virus infects both wild-type and TLR2-/- microglial cells with similar efficiencies [3], apoptotic cell death was significantly lower in TLR2-/- cells. In addition, a large number of pro-apoptotic genes were clearly down-regulated in TLR2-/- cells at a time when wild-type cells were actively undergoing apoptosis. We have previously demonstrated that at early time points the production of proinflammatory immune mediators did not occur in TLR2-/- microglia but they were produced robustly in wild-type cells [3]. However, TNF-α was still expressed in TLR2-/- cells at approximately 50% of the level seen in wild-type cells, and it is possible that immune mediators such as TNF-α produced early in infection, might induce apoptosis. In a recent study, we deduced apoptotic pathways occurring in primary glial cells infected with HSV and found that TNF-α pathway was active in HSV-infected microglial cells [10]. Taken together, these data indicate that HSV infection of microglial cells activates TLR2 signaling which, in turn, induces the production of immune mediators and eventually leads to cell death.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

RNA and JRL conceived the study and its design, and analyzed the data. RNA and SH performed the experiments. RNA drafted the manuscript. All authors read and approved the final manuscript.
  14 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Immune function of microglia.

Authors:  F Aloisi
Journal:  Glia       Date:  2001-11       Impact factor: 7.452

3.  Neuroprotective role of IL-4 against activated microglia.

Authors:  C C Chao; T W Molitor; S Hu
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

4.  Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2.

Authors:  A O Aliprantis; R B Yang; M R Mark; S Suggett; B Devaux; J D Radolf; G R Klimpel; P Godowski; A Zychlinsky
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

5.  The role of toll-like receptors in herpes simplex infection in neonates.

Authors:  Evelyn A Kurt-Jones; John Belko; Catherine Yu; Peter E Newburger; Jennifer Wang; Melvin Chan; David M Knipe; Robert W Finberg
Journal:  J Infect Dis       Date:  2005-01-18       Impact factor: 5.226

6.  Differential apoptotic signaling in primary glial cells infected with herpes simplex virus 1.

Authors:  Rajagopal N Aravalli; Shuxian Hu; Timothy N Rowen; Genya Gekker; James R Lokensgard
Journal:  J Neurovirol       Date:  2006-12       Impact factor: 2.643

7.  Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs.

Authors:  Julie K Olson; Stephen D Miller
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

8.  Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9.

Authors:  Anne Krug; Gary D Luker; Winfried Barchet; David A Leib; Shizuo Akira; Marco Colonna
Journal:  Blood       Date:  2003-10-16       Impact factor: 22.113

9.  Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways.

Authors:  Hubertus Hochrein; Beatrix Schlatter; Meredith O'Keeffe; Cornelia Wagner; Frank Schmitz; Matthias Schiemann; Stefan Bauer; Mark Suter; Hermann Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-22       Impact factor: 11.205

10.  Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis.

Authors:  Evelyn A Kurt-Jones; Melvin Chan; Shenghua Zhou; Jennifer Wang; George Reed; Roderick Bronson; Michelle M Arnold; David M Knipe; Robert W Finberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-22       Impact factor: 11.205

View more
  21 in total

1.  Human cytomegalovirus activation of ERK and myeloid cell leukemia-1 protein correlates with survival of latently infected cells.

Authors:  Matthew B Reeves; Abagail Breidenstein; Teresa Compton
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

Review 2.  Immunomodulatory Strategies in Herpes Simplex Virus Encephalitis.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Clin Microbiol Rev       Date:  2020-02-12       Impact factor: 26.132

3.  Essential role of toll-like receptor 2 in morphine-induced microglia activation in mice.

Authors:  Yi Zhang; Hui Li; Yi Li; Xiuli Sun; Mengyang Zhu; Gregory Hanley; Gene Lesage; Deling Yin
Journal:  Neurosci Lett       Date:  2010-12-02       Impact factor: 3.046

Review 4.  Innate immune sensing of DNA viruses.

Authors:  Vijay A K Rathinam; Katherine A Fitzgerald
Journal:  Virology       Date:  2011-02-18       Impact factor: 3.616

5.  The immune response to herpes simplex virus encephalitis in mice is modulated by dietary vitamin E.

Authors:  Patricia A Sheridan; Melinda A Beck
Journal:  J Nutr       Date:  2008-01       Impact factor: 4.798

6.  Herpes simplex virus induces neural oxidative damage via microglial cell Toll-like receptor-2.

Authors:  Scott J Schachtele; Shuxian Hu; Morgan R Little; James R Lokensgard
Journal:  J Neuroinflammation       Date:  2010-06-28       Impact factor: 8.322

7.  Herpes simplex virus US3 tegument protein inhibits Toll-like receptor 2 signaling at or before TRAF6 ubiquitination.

Authors:  Jayita Sen; Xueqiao Liu; Richard Roller; David M Knipe
Journal:  Virology       Date:  2013-03-07       Impact factor: 3.616

8.  TLR6 modulates first trimester trophoblast responses to peptidoglycan.

Authors:  Vikki M Abrahams; Paulomi B Aldo; Shaun P Murphy; Irene Visintin; Kaori Koga; Gabriella Wilson; Roberto Romero; Surendra Sharma; Gil Mor
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

Review 9.  Live or let die: manipulation of cellular suicide programs by murine cytomegalovirus.

Authors:  Wiebke Handke; Eva Krause; Wolfram Brune
Journal:  Med Microbiol Immunol       Date:  2012-09-11       Impact factor: 4.148

10.  Toll-like receptors and viruses: induction of innate antiviral immune responses.

Authors:  Angeliki Xagorari; Katerina Chlichlia
Journal:  Open Microbiol J       Date:  2008-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.